During HCV infection, SREBP1c is activated, subsequently upregulating the de novo fatty acid synthesis pathway, which plays a critical role in HCV-induced hepatic steatosis (Park et al., 2009, Meng et al., 2019). The gene discussed is SREBF1; the disease is fatty liver disease.